Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Mural Oncology PLC (MURA) had Return on Tangible Equity of -91.47% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-128.51M |
|
-- |
|
-- |
|
$138.26M |
|
$-138.26M |
|
$9.75M |
|
$-128.51M |
|
$-128.51M |
|
$-128.51M |
|
$-128.51M |
|
$-128.51M |
|
$-128.51M |
|
$-138.26M |
|
$-134.75M |
|
16.95M |
|
16.95M |
|
$-7.58 |
|
$-7.58 |
|
| Balance Sheet Financials | |
$152.92M |
|
$7.71M |
|
$16.48M |
|
$169.39M |
|
$26.20M |
|
-- |
|
$2.70M |
|
$28.89M |
|
$140.50M |
|
$140.50M |
|
$140.50M |
|
17.09M |
|
| Cash Flow Statement Financials | |
$-128.54M |
|
$-25.33M |
|
$0.20M |
|
$271.11M |
|
$117.43M |
|
$-153.68M |
|
$5.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-128.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-91.47% |
|
|
Return on Tangible Equity |
-91.47% |
-75.87% |
|
-91.47% |
|
$8.22 |
|
$-7.58 |
|
$-7.58 |
|